Status:
COMPLETED
Impact of Pharmaceutical Care on Drug-related Problems in Patients With Parkinson's Disease
Lead Sponsor:
Mahidol University
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the impact of pharmaceutical care on the number of drug-related problems, clinical outcomes and quality of life of patients with Parkinson's disease.
Detailed Description
This is a randomized controlled study that will be conducted in Parkinson's disease and movement disorders clinic, Siriraj Hospital, Thailand. The participants and assessors evaluating MDS-UPDRS were ...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Diagnosed with idiopathic Parkinson's disease according to the UK Parkinson's disease Society Brain Bank Criteria for at least 3 years
- Modified Hoehn and Yahr stage 2-4
- Patient had received at least one of antiparkinsonian drugs the following: levodopa, MAO-B inhibitors, dopamine agonists, COMT inhibitors, amantadine, and trihexyphenidyl
- Patient has given a written informed consent to participate in the study. If the patients are unable to give an informed consent, it must be obtained from the caregiver.
Exclusion
- Patient is unable to communicate via telephone or mobile phone or internet.
- Patient who is terminal illness
- Patient who is bed ridden
- Patient with other movement disorders include corticobasal syndrome, multiple system atrophy, progressive supranuclear palsy and essential tremor
- Moderate to severe dementia as evidenced by Mini Mental State Examination (MMSE) or Thai Mental State Examination (TMSE) less than 20 and without the caregiver
- Patient who is planning to undergo surgery or have a history of surgical treatment for Parkinson's disease such as pallidotomy, thalamotomy, or deep brain stimulation
- Patient with hearing impairments which affects communication via telephone or electronic media
- Unable to communicate Thai language
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05410210
Start Date
March 11 2022
End Date
January 23 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj hospital
Bangkok, Thailand, 10700